Re (RMAX) EBIT (2012 - 2026)

Re (RMAX) has reported EBIT for 15 consecutive years, with $1.5 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, EBIT fell 89.21% year-over-year to $1.5 million in Q2 2026; TTM through Jun 2026 was $21.3 million, a 45.18% decrease from a year earlier, with the FY2025 full-year figure at $47.0 million, up 17.08% from the prior year.
• EBIT was $1.5 million for Q2 2026 at Re, up from -$7.8 million in the prior quarter.
• Over five years, EBIT peaked at $18.3 million in Q3 2025 and troughed at -$21.0 million in Q3 2023.
• A 5-year average of $6.0 million and a median of $7.3 million in 2022 frame the typical range for EBIT.
• Across the five-year window, EBIT sank 501.11% in 2023 and surged 172.44% in 2024, its largest moves.
• Over 5 years, EBIT stood at $8.5 million in 2022, then sank by 214.58% to -$9.7 million in 2023, then soared by 144.03% to $4.3 million in 2024, then soared by 118.17% to $9.3 million in 2025, then slumped by 83.73% to $1.5 million in 2026.
• The last three EBIT figures came in at $1.5 million (Q2 2026), -$7.8 million (Q1 2026), and $9.3 million (Q4 2025), per Business Quant data.